Melanogenesis during the anagen-catagen-telogen transformation of the murine hair cycle.

PubWeight™: 1.27‹?› | Rank: Top 10%

🔗 View Article (PMID 8006449)

Published in J Invest Dermatol on June 01, 1994


A Slominski1, R Paus, P Plonka, A Chakraborty, M Maurer, D Pruski, S Lukiewicz

Author Affiliations

1: Department of Pathology and Laboratory Medicine, Albany Medical College, New York 12208.

Articles citing this

Hair follicle pigmentation. J Invest Dermatol (2005) 1.84

Analysis of apoptosis during hair follicle regression (catagen) Am J Pathol (1997) 1.82

Morpho-regulation of ectodermal organs: integument pathology and phenotypic variations in K14-Noggin engineered mice through modulation of bone morphogenic protein pathway. Am J Pathol (2004) 1.72

The magnitude of hedgehog signaling activity defines skin tumor phenotype. EMBO J (2003) 1.72

Differential expression of a cutaneous corticotropin-releasing hormone system. Endocrinology (2003) 1.46

Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia. Am J Pathol (1997) 1.17

Aging of the hair follicle pigmentation system. Int J Trichology (2009) 1.00

Neurogenic inflammation in stress-induced termination of murine hair growth is promoted by nerve growth factor. Am J Pathol (2004) 0.95

Impaired skin and hair follicle development in Runx2 deficient mice. Dev Biol (2008) 0.89

Melanocytes, melanocyte stem cells, and melanoma stem cells. Clin Dermatol (2013) 0.87

The peripheral clock regulates human pigmentation. J Invest Dermatol (2014) 0.85

Melanocyte stem cells as potential therapeutics in skin disorders. Expert Opin Biol Ther (2014) 0.80

Premature graying as a consequence of compromised antioxidant activity in hair bulb melanocytes and their precursors. PLoS One (2014) 0.80

FGF5 and the murine hair cycle. Arch Dermatol Res (1996) 0.80

Wnt10b promotes differentiation of mouse hair follicle melanocytes. Int J Med Sci (2013) 0.79

Biophysical monitoring of melanogenesis as a tool for pigment and hair research. Arch Dermatol Res (1995) 0.79

Mapping of the Faded (fe) Gene to a Region between D10mit191 and D10mit44 on Mouse Chromosome 10. Lab Anim Res (2011) 0.78

The melanocyte photosensory system in the human skin. Springerplus (2013) 0.77

Differential Expression of Proteins Associated with the Hair Follicle Cycle - Proteomics and Bioinformatics Analyses. PLoS One (2016) 0.76

HGF/SF increases number of skin melanocytes but does not alter quality or quantity of follicular melanogenesis. PLoS One (2013) 0.76

Erbium: YAG laser (2,940 nm) treatment stimulates hair growth through upregulating Wnt 10b and β-catenin expression in C57BL/6 mice. Int J Clin Exp Med (2015) 0.75

Comparative Transcriptome Analysis of Raccoon Dog Skin to Determine Melanin Content in Hair and Melanin Distribution in Skin. Sci Rep (2017) 0.75

Paracrine Secreted Frizzled-Related Protein 4 Inhibits Melanocytes Differentiation in Hair Follicle. Stem Cells Int (2017) 0.75

Clinical application of intense pulsed light depilation technology in total auricular reconstruction. Lasers Med Sci (2017) 0.75

Preclinical and Clinical Studies Demonstrate That the Proprietary Herbal Extract DA-5512 Effectively Stimulates Hair Growth and Promotes Hair Health. Evid Based Complement Alternat Med (2017) 0.75

Articles by these authors

A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol (2001) 6.12

Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature (2000) 5.86

Sonic hedgehog signaling is essential for hair development. Curr Biol (1998) 5.58

Controls of hair follicle cycling. Physiol Rev (2001) 5.49

EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy (2009) 4.10

Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo. Nat Biotechnol (1999) 3.97

EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy (2009) 3.86

CENP-C, an autoantigen in scleroderma, is a component of the human inner kinetochore plate. Cell (1992) 3.70

The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy (2014) 3.10

Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro. J Clin Invest (1998) 3.01

Noggin is a mesenchymally derived stimulator of hair-follicle induction. Nat Cell Biol (1999) 2.99

Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev (2000) 2.98

A comprehensive guide for the recognition and classification of distinct stages of hair follicle morphogenesis. J Invest Dermatol (1999) 2.92

Interleukin-15 protects from lethal apoptosis in vivo. Nat Med (1997) 2.22

Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17

RB1 protein in normal and malignant human colorectal tissue and colon cancer cell lines. FASEB J (1993) 2.11

Home versus hospital deliveries: follow up study of matched pairs for procedures and outcome. Zurich Study Team. BMJ (1996) 2.10

Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling. FASEB J (2000) 2.09

Noggin is required for induction of the hair follicle growth phase in postnatal skin. FASEB J (2001) 1.95

Melanogenesis is coupled to murine anagen: toward new concepts for the role of melanocytes and the regulation of melanogenesis in hair growth. J Invest Dermatol (1993) 1.88

Mast cells as sentinels of innate immunity. Curr Opin Immunol (1999) 1.85

Factors responsible for differences between asymptomatic subjects and patients presenting an IgE sensitization to allergens. A GA2LEN project. Allergy (2006) 1.84

Mast cells can secrete vascular permeability factor/ vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of fc epsilon receptor I expression. J Exp Med (1998) 1.84

Analysis of apoptosis during hair follicle regression (catagen) Am J Pathol (1997) 1.82

Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature (1997) 1.78

ESR studies of O2 uptake by Chinese hamster ovary cells during the cell cycle. Proc Natl Acad Sci U S A (1982) 1.77

Graying: gerontobiology of the hair follicle pigmentary unit. Exp Gerontol (2001) 1.75

Prevalence of head and neck cancers in the north east-An institutional study. Indian J Otolaryngol Head Neck Surg (2006) 1.72

Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15. Blood (1999) 1.71

EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria. Allergy (2009) 1.65

Autologous whole blood injections to patients with chronic urticaria and a positive autologous serum skin test: a placebo-controlled trial. Dermatology (2006) 1.65

What are melanocytes really doing all day long...? Exp Dermatol (2009) 1.65

Retracted Death deflected: IL-15 inhibits TNF-alpha-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL-15Ralpha chain. FASEB J (1999) 1.60

Detection of proopiomelanocortin-derived antigens in normal and pathologic human skin. J Lab Clin Med (1993) 1.58

Molecular cloning, chromosome mapping and characterization of UBQLN3 a testis-specific gene that contains an ubiquitin-like domain. Gene (2000) 1.57

How to assess disease activity in patients with chronic urticaria? Allergy (2008) 1.55

EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria. Allergy (2006) 1.55

Melanocytes as "sensory" and regulatory cells in the epidermis. J Theor Biol (1993) 1.55

Embolization of biologic glue during repair of aortic dissection. Ann Thorac Surg (1995) 1.52

How best to fight that nasty itch - from new insights into the neuroimmunological, neuroendocrine, and neurophysiological bases of pruritus to novel therapeutic approaches. Exp Dermatol (2005) 1.51

Murine in vivo L-band ESR spin-label oximetry with a loop-gap resonator. Magn Reson Med (1986) 1.50

Control of murine hair follicle regression (catagen) by TGF-beta1 in vivo. FASEB J (2000) 1.48

A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist. Proc Natl Acad Sci U S A (2001) 1.43

Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper. Allergy (2010) 1.42

The human hair follicle immune system: cellular composition and immune privilege. Br J Dermatol (2000) 1.42

Failure of topical estrogen receptor agonists and antagonists to alter murine hair follicle cycling. J Invest Dermatol (1998) 1.40

Fatal recurrent subarachnoid hemorrhage after complete endovascular aneurysm occlusion. AJNR Am J Neuroradiol (2006) 1.40

The definition and diagnostic testing of physical and cholinergic urticarias--EAACI/GA2LEN/EDF/UNEV consensus panel recommendations. Allergy (2009) 1.39

The 'melanocyte-keratin' mystery revisited: neither normal human epidermal nor hair follicle melanocytes express keratin 16 or keratin 6 in situ. Br J Dermatol (2009) 1.39

Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else? Exp Dermatol (2008) 1.39

The TGF-beta2 isoform is both a required and sufficient inducer of murine hair follicle morphogenesis. Dev Biol (1999) 1.38

The role of the hairless (hr) gene in the regulation of hair follicle catagen transformation. Am J Pathol (1999) 1.38

Thoracic epidural catheterization leading to delayed transient neurological symptoms with normal imaging findings. Acta Anaesthesiol Scand (2008) 1.38

Abundant production of brain-derived neurotrophic factor by adult visceral epithelia. Implications for paracrine and target-derived Neurotrophic functions. Am J Pathol (1999) 1.37

Role of nerve growth factor in a mouse model of allergic airway inflammation and asthma. Eur J Immunol (1998) 1.37

Schnitzler's syndrome: diagnosis, treatment, and follow-up. Allergy (2013) 1.35

Alkaline phosphatase activity and localization during the murine hair cycle. Br J Dermatol (1994) 1.34

Molecular and functional aspects of the hairless (hr) gene in laboratory rodents and humans. Exp Dermatol (1998) 1.33

NMR solution structure of a complex of calmodulin with a binding peptide of the Ca2+ pump. Biochemistry (1999) 1.33

Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53. Genes Dev (1998) 1.31

Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis? J Immunol (2000) 1.29

Inhibition of melanogenesis as an adjuvant strategy in the treatment of melanotic melanomas: selective review and hypothesis. Anticancer Res (1999) 1.29

p53 is essential for chemotherapy-induced hair loss. Cancer Res (2000) 1.29

Active hair growth (anagen) is associated with angiogenesis. J Invest Dermatol (2000) 1.29

EAACI/GA2LEN/EDF guideline: management of urticaria. Allergy (2006) 1.28

Involvement of hepatocyte growth factor/scatter factor and met receptor signaling in hair follicle morphogenesis and cycling. FASEB J (2000) 1.26

Senile hair graying: H2O2-mediated oxidative stress affects human hair color by blunting methionine sulfoxide repair. FASEB J (2009) 1.25

A simultaneous (15)N, (1)H- and (13)C, (1)H-HSQC with sensitivity enhancement and a heteronuclear gradient echo. J Biomol NMR (1995) 1.25

Impaired mast cell development and innate immunity in Mac-1 (CD11b/CD18, CR3)-deficient mice. J Immunol (1998) 1.25

Strategy for qualitative and quantitative analysis in proteomics based on signature peptides. J Chromatogr B Biomed Sci Appl (2000) 1.25

Management of alopecia areata. BMJ (2010) 1.25

Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity. Br J Dermatol (2006) 1.24

Differential expression and activity of melanogenesis-related proteins during induced hair growth in mice. J Invest Dermatol (1991) 1.24

Melanoma x macrophage hybrids with enhanced metastatic potential. Clin Exp Metastasis (1998) 1.23

Improved pharmacokinetic properties of a polyethylene glycol-modified form of interferon-beta-1a with preserved in vitro bioactivity. J Pharmacol Exp Ther (2001) 1.22

E- and P-cadherin expression during murine hair follicle morphogenesis and cycling. Exp Dermatol (1999) 1.22

Characterization of functional vanilloid receptors expressed by mast cells. Blood (1998) 1.21

Donor DNA in a renal cell carcinoma metastasis from a bone marrow transplant recipient. Bone Marrow Transplant (2004) 1.21

Retracted The IL-15R alpha chain signals through association with Syk in human B cells. J Immunol (2001) 1.20

Hair cycle-dependent plasticity of skin and hair follicle innervation in normal murine skin. J Comp Neurol (1997) 1.20

p53 Involvement in the control of murine hair follicle regression. Am J Pathol (2001) 1.19

The eukaryotic initiation factor 2-associated 67-kDa polypeptide (p67) plays a critical role in regulation of protein synthesis initiation in animal cells. Proc Natl Acad Sci U S A (1992) 1.18

Cutaneous expression of CRH and CRH-R. Is there a "skin stress response system?". Ann N Y Acad Sci (1999) 1.18

Hair follicle expression of 1,25-dihydroxyvitamin D3 receptors during the murine hair cycle. Br J Dermatol (1994) 1.18

Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia. Am J Pathol (1997) 1.17

Indications for a 'brain-hair follicle axis (BHA)': inhibition of keratinocyte proliferation and up-regulation of keratinocyte apoptosis in telogen hair follicles by stress and substance P. FASEB J (2001) 1.17

Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria. Allergy (2014) 1.16

Re-engineering the toilet for sustainable waste water management. Environ Sci Technol (2001) 1.14

What causes alopecia areata? Exp Dermatol (2013) 1.14

Culture, colonialism, and psychiatry. Lancet (1991) 1.13

Rupatadine in allergic rhinitis and chronic urticaria. Allergy (2008) 1.13

Epidemiology of urticaria: a representative cross-sectional population survey. Clin Exp Dermatol (2010) 1.12

Antibacterial effects of cefroxadine, cephalexin and cephradine in a new in vitro pharmacokinetic model. J Antibiot (Tokyo) (1982) 1.11

Up-dosing with bilastine results in improved effectiveness in cold contact urticaria. Allergy (2013) 1.09

Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica. J Neurol Neurosurg Psychiatry (2008) 1.08

Algorithm for application of Fourier analysis for biorhythmic baselines of pharmacodynamic indirect response models. Chronobiol Int (2000) 1.07

Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells. Oncogene (1997) 1.07

The German version of the Chronic Urticaria Quality-of-Life Questionnaire: factor analysis, validation, and initial clinical findings. Allergy (2009) 1.07